- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- monomer
- Ligands
- 1 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 31 x IOD: IODIDE ION(Non-functional Binders)
IOD.2: 2 residues within 4Å:- Chain A: H.23
- Ligands: IOD.3
Ligand excluded by PLIPIOD.3: 3 residues within 4Å:- Chain A: A.78, D.79
- Ligands: IOD.2
Ligand excluded by PLIPIOD.4: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.5: 2 residues within 4Å:- Chain A: I.24, R.27
Ligand excluded by PLIPIOD.6: 1 residues within 4Å:- Chain A: E.28
Ligand excluded by PLIPIOD.7: 1 residues within 4Å:- Chain A: E.44
Ligand excluded by PLIPIOD.8: 4 residues within 4Å:- Chain A: A.49, R.213, K.214, K.218
Ligand excluded by PLIPIOD.9: 1 residues within 4Å:- Chain A: F.51
Ligand excluded by PLIPIOD.10: 2 residues within 4Å:- Chain A: K.105
- Ligands: IOD.11
Ligand excluded by PLIPIOD.11: 5 residues within 4Å:- Chain A: S.80, K.105, H.254
- Ligands: IOD.10, IOD.12
Ligand excluded by PLIPIOD.12: 5 residues within 4Å:- Chain A: K.105, H.254, P.257, A.316
- Ligands: IOD.11
Ligand excluded by PLIPIOD.13: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.14: 1 residues within 4Å:- Chain A: R.365
Ligand excluded by PLIPIOD.15: 1 residues within 4Å:- Chain A: Y.277
Ligand excluded by PLIPIOD.16: 2 residues within 4Å:- Chain A: A.126, S.129
Ligand excluded by PLIPIOD.17: 4 residues within 4Å:- Chain A: E.140, R.141, S.166, K.167
Ligand excluded by PLIPIOD.18: 2 residues within 4Å:- Chain A: R.153, I.162
Ligand excluded by PLIPIOD.19: 2 residues within 4Å:- Chain A: D.160, P.233
Ligand excluded by PLIPIOD.20: 1 residues within 4Å:- Chain A: R.231
Ligand excluded by PLIPIOD.21: 3 residues within 4Å:- Chain A: T.185, D.186, G.242
Ligand excluded by PLIPIOD.22: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.23: 3 residues within 4Å:- Chain A: G.239, E.240, T.243
Ligand excluded by PLIPIOD.24: 4 residues within 4Å:- Chain A: S.289, D.290, Q.295
- Ligands: IOD.25
Ligand excluded by PLIPIOD.25: 3 residues within 4Å:- Chain A: D.290, Q.295
- Ligands: IOD.24
Ligand excluded by PLIPIOD.26: 2 residues within 4Å:- Chain A: R.389
- Ligands: FDA.1
Ligand excluded by PLIPIOD.27: 2 residues within 4Å:- Chain A: D.300, K.304
Ligand excluded by PLIPIOD.28: 1 residues within 4Å:- Chain A: K.304
Ligand excluded by PLIPIOD.29: 2 residues within 4Å:- Chain A: R.318, F.328
Ligand excluded by PLIPIOD.30: 4 residues within 4Å:- Chain A: D.339, Q.374, Q.381, R.384
Ligand excluded by PLIPIOD.31: 2 residues within 4Å:- Chain A: Q.381, R.384
Ligand excluded by PLIPIOD.32: 2 residues within 4Å:- Chain A: E.377
- Ligands: FDA.1
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., SAD phasing using iodide ions in a high-throughput structural genomics environment. J.STRUCT.FUNCT.GENOM. (2011)
- Release Date
- 2010-11-10
- Peptides
- Acyl-CoA dehydrogenase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- monomer
- Ligands
- 1 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 31 x IOD: IODIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., SAD phasing using iodide ions in a high-throughput structural genomics environment. J.STRUCT.FUNCT.GENOM. (2011)
- Release Date
- 2010-11-10
- Peptides
- Acyl-CoA dehydrogenase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A